Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma:...
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
mRCC: Are we doing all we can to manage adverse events?
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
mRCC: Real-world experience: achieving efficacy beyond clinical trials
Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015
mRCC: Understanding the patient's perspective
Dr David Cella - Northwestern University, Chicago, USA
mRCC: Understanding the patient's perspective ( Dr David Cella - Northwestern University, Chicago, USA )
11 Feb 2015
mRCC: Panel discussion
Prof Bernard Escudier, Dr Nizar Tannir, Dr David Cella
mRCC: Panel discussion ( Prof Bernard Escudier, Dr Nizar Tannir, Dr David Cella )
11 Feb 2015
mRCC: Closing remarks
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
mRCC: Closing remarks ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Welcome and introduction
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to...
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015
Optimizing survival in advanced prostate cancer: CHAARTED: What are the...
Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future? ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Learnings from real life...
Prof Bertrand Tombal - Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Learnings from real life practice ( Prof Bertrand Tombal - Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing Survival in Advanced Prostate Cancer: Conclusion
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing Survival in Advanced Prostate Cancer: Conclusion ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation